NCT00644384View on ClinicalTrials.gov

Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Non-melanomatous Skin Cancer
Interventions
DRUG

acitretin

GENETIC

gene expression analysis

GENETIC

northern blotting

GENETIC

polymerase chain reaction

GENETIC

protein expression analysis

OTHER

laboratory biomarker analysis

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER